Indaptus Therapeutics, Inc. INDP
3.85
(0.15)
(3.75%)
as of 25 Sep
- Market cap
- $606.8M
- P/E
- 0.0×
Follow INDP
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(317.98%) | (588.41%) | (931.79%) | (318.04%) | |
| (223.71%) | (250.45%) | (496.74%) | (163.84%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(401.16%) | (661.53%) | (1,511.15%) | (135.62%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(15.07) | (15.34) | (1.53) | (0.13) | |
Free Cash Flow |
(15.03) | (14.82) | (16.79) | (14.70) | |
| Other line items | |||||
Cash ROIC |
(144.07%) | (127.14%) | (611.41%) | (64.10%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.71 | 0.89 | 0.95 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(15.07) | (15.34) | (1.53) | (0.13) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates